Cry baby blues: L reuteri probiotic not backed for Colic

By Shane STARLING

- Last updated on GMT

Related tags Lactobacillus reuteri Probiotic Baby colic

L. reuteri, "did not reduce crying or fussing in infants with colic...". IPA says the study is strain-specific and flawed.
L. reuteri, "did not reduce crying or fussing in infants with colic...". IPA says the study is strain-specific and flawed.
A study involving 167 breastfed and probiotic formula fed ‘excessive crying’ infants has found no benefits for the formula-fed ones, even though other studies showed probiotics could reduce the malady.

Responding the International Probiotics Association (IPA) said the strain-specific research could not be generalised to all probiotics.

The study, published this month in the British Medical Journal,​  involved 167 babies split into two groups, with 85 receiving the Lactobacillus reuteri​-fortified probiotic formula for one month.

L. reuteri​ treatment did not lead to changes in infant faecal microbial diversity, E coli colonisation, or calprotectin levels.

The researchers, led by Valerie Sung, a paediatrician at the Centre for Community Child Health at the Royal Children’s Hospital in Parkville, Victoria, said the probiotic formula, "did not reduce crying or fussing in infants with colic, nor was it effective in improving infant sleep, maternal mental health, family or infant functioning, or quality of life."

They added, "probiotics therefore cannot be routinely recommended for all infants with colic."

The IPA’s Nevena Krstić commented that due to the result for L. reuteri ​in the study, “it shouldn`t be interpreted that all probiotics would yield the same null effect.”

She added: “It is worthy to note that this same probiotic was shown to be efficacious in previous studies under different clinical settings.”

Krstić said the study had limitations including whether the infants had other health issues and potential blinding and dosage issues.

Colic affects about 20% of babies.

Professor Sung and others recently published a systematic review​  that collated data from more than 1,800 infants who took part in 12 randomised clinical trials.

They found data to be insufficient to support using L.reuteri​ to manage colic - especially in formula-fed babies. However they noted that there is some evidence to suggest the strain may an effective treatment for crying infants who are breastfed exclusively and have colic.

Source:

British Medical Journal

April 2014 (BMJ 2014;348:g2107)

‘Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial’

Authors: Valerie Sung et al…

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Related suppliers

Follow us

Products

View more

Webinars